Similar to pancreatic cancer cells that express c-MYC or mutant KRAS in a ligand-controlled manner19,20, the survival of KRASG12D-expressing mammary tumor cells that are being maintained in culture did not rely on the oncogenic driver (Fig. 6b). The gene discussed is KRAS; the disease is pancreatic neoplasm.